Ultimately, PON1 polymorphisms were analyzed in the remaining 365 women with a clinical and histological diagnosis of BC (mean age 48 ± 9 years) and 378 age-matched healthy women (mean age 48 ± 8 years). Here, PON1 is linked to breast cancer.